The importance of the assessment of pulmonary function in COPD

Medical Clinics of North America

Volumn 96, Issue 4, 2012, Pages 745-752

  Bailey, Kristina L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Chronic obstructive pulmonary disease; Diffusing capacity of the lung for carbon monoxide; Lung volumes; Spirometry

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CARBON MONOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; SHORT ACTING DRUG;

AIRWAY OBSTRUCTION; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; EMPHYSEMA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL RESIDUAL CAPACITY; GOLD STANDARD; HUMAN; HYPERINFLATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VOLUME; MORTALITY; OXIMETRY; PLETHYSMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY REHABILITATION; RESIDUAL VOLUME; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK FACTOR; SPIROMETRY; TOTAL LUNG CAPACITY;

ASTHMA; BRONCHODILATOR AGENTS; DIAGNOSIS, DIFFERENTIAL; FORCED EXPIRATORY VOLUME; HUMANS; LUNG VOLUME MEASUREMENTS; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VITAL CAPACITY;

EID: 84863855853     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.04.011     Document Type: Review

References (19)

1. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176(6):532-555.
2. From the global strategy for the diagnosis, management and prevention of COPD. 2011. Available at: Accessed April 1, 2012. http://www.goldcopd.org/.
3. Mannino D.M., Gagnon R.C., Petty T.L., et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000, 160(11):1683-1689.
4. Walker P.P., Mitchell P., Diamantea F., et al. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J 2006, 28(5):945-952.
5. Han M.K., Kim M.G., Mardon R., et al. Spirometry utilization for COPD: how do we measure up?. Chest 2007, 132(2):403-409.
6. Joo M.J., Au D.H., Lee T.A. Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care. Transl Res 2009, 154(3):103-110.
7. Owens G.R., Rogers R.M., Pennock B.E., et al. The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N Engl J Med 1984, 310(19):1218-1221.
8. Qaseem A., Wilt T.J., Weinberger S.E., et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011, 155(3):179-191.
9. Hardie J.A., Buist A.S., Vollmer W.M., et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002, 20(5):1117-1122.
10. Swanney M.P., Ruppel G., Enright P.L., et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008, 63(12):1046-1051.
11. Cerveri I., Corsico A.G., Accordini S., et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008, 63(12):1040-1045.
12. Mannino D.M., Sonia Buist A., Vollmer W.M. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?. Thorax 2007, 62(3):237-241.
13. Allen S.C., Charlton C., Backen W., et al. Performing slow vital capacity in older people with and without cognitive impairment-is it useful?. Age Ageing 2010, 39(5):588-591.
14. Jing J.Y., Huang T.C., Cui W., et al. Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? a metaanalysis. Chest 2009, 135(4):991-998.
15. Mahler D.A., Ward J., Waterman L.A., et al. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest 2009, 136(6):1473-1479.
16. Lin S.H., Kuo P.H., Kuo S.H., et al. Severity staging of chronic obstructive pulmonary disease: differences in pre- and post-bronchodilator spirometry. Yonsei Med J 2009, 50(5):672-676.
17. Chavannes N., Schermer T., Akkermans R., et al. Impact of spirometry on GPs' diagnostic differentiation and decision-making. Respir Med 2004, 98(11):1124-1130.
18. Anthonisen N.R., Wright E.C., Hodgkin J.E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986, 133(1):14-20.
19. Cote C.G., Pinto-Plata V.M., Marin J.M., et al. The modified BODE index: validation with mortality in COPD. Eur Respir J 2008, 32(5):1269-1274.